Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2015-06-24 |
Moberg Pharma (Sweden) |
€ 0.9 million |
grant |
European Eurostars Programme (EU) |
Infectious diseases |
Grant |
2015-06-23 |
Abivax (France) |
€57.7 million |
IPO |
|
Infectious diseases |
IPO |
2015-06-23 |
Advanced Accelerator Applications (France) |
€23 million |
financing round |
Adage Capital Management (USA - MA) funds and accounts managed by T. Rowe Price Associates (USA - MD) and Rock Springs Capital Management (USA - MD) |
Cancer - Oncology - Diagnostic - Technology - Services |
Financing round |
2015-06-23 |
bluebird bio (USA - MA) |
$477.2 million |
private placement |
|
Rare diseases - Genetic diseases - Hematological diseases |
Private placement |
2015-06-23 |
Biotie Therapies (Finland) |
$56.6 million (€50,23 million) |
IPO |
|
Neurological diseases - Mental diseases |
Establishment of a new subsidiary in the EU |
2015-06-19 |
Galapagos (Belgium) |
€4.4 million |
capital increase |
|
|
Capital increase |
2015-06-17 |
Amicus Therapeutics (USA - NJ) |
$258.8 million |
financing round |
|
Rare diseases - Genetic diseases |
Financing round |
2015-06-16 |
BioCardia (USA - CA) |
|
|
|
Cardiovascular diseases |
IPO |
2015-06-16 |
Affiris (Austria) |
€ 10 million |
capital increase |
Santo Holding (Germany) MIG Verwaltungs AG (Germany) |
Neurodegenerative diseases |
Capital increase |
2015-06-16 |
Axovant Sciences (Bermuda - USA - NY) |
$362 million |
IPO |
|
Mental diseases - Neurodegenerative diseases |
IPO |
2015-06-15 |
BioInvent (Sweden) |
€ 8.1 million |
private placement |
|
|
Private placement |
2015-06-12 |
Atyr Pharma (USA - CA) |
$ 75 million |
IPO |
|
Rare diseases |
IPO |
2015-06-11 |
Oramed Pharmaceuticals (Israel) |
$5.36 milion |
private placement |
|
|
Private placement |
2015-06-11 |
Medgenics (USA - Israel) |
$ 3.4 million |
grant |
Office of the Chief Scientist (OCS -Israel) |
Rare diseases |
Grant |
2015-06-10 |
Melinta Therapeutics (USA - CT) |
$67 million |
financing round |
Malin Corporation (Ireland) Vatera Healthcare Partners (USA - NY) other undisclosed existing investors |
Infectious diseases |
Financing round |
2015-06-10 |
Melinta Therapeutics (USA - CT) |
$67 million |
series D financing round |
Malin Corporation (Ireland) other existing investors, including Vatera Healthcare Partners.(USA - NY) |
Infectious diseases |
Series D financing round |
2015-06-03 |
Auspherix (Australia) |
£6 million |
series A financing round |
Imperial Innovations Group (UK) Medical Research Commercialisation Fund (MRCF) (Australia) |
Infectious diseases |
Series A financing round |
2015-06-02 |
Intarcia Therapeutics (USA - CA) |
$300 million |
financing round |
|
Metabolic diseases |
Financing round |
2015-05-28 |
RXi Pharmaceuticals (USA - MA) |
$10.4 million |
private placement |
|
Dermatological diseases - Ophtalmological diseases |
Private placement |
2015-05-27 |
Fate Therapeutics (USA - CA) |
$32 million |
fundraising |
|
Cancer - Oncology - Rare diseases - Genetic diseases - Hematological diseases |
Fundraising |